美国FDA药品DMF数据库
(U.S. FDA Drug Master Files)
DMF号码 DMF状态 DMF类型 提交日期 持有人 关联主题/药物名称
40558 A IV 2024/10/17 CIPLA LTD N-DODECYL-BETA-D-MALTOSIDE
40573 A II 2024/10/17 ANYGEN CO LTD GANIRELIX ACETATE
40680 A III 2024/10/17 SICHUAN LANGZHONG GUANGMING GLASS CO LTD INJECTION VIALS MADE OF MOULDED MIDDLE BOROSILICATE GLASS
40681 A III 2024/10/17 SICHUAN LANGZHONG GUANGMING GLASS CO LTD INFUSION BOTTLES MADE OF MIDDLE BOROSILICATE GLASS
40523 A II 2024/10/16 APITORIA PHARMA PRIVATE LTD ROSUVASTATIN CALCIUM USP (PROCESS-II)
40582 A II 2024/10/16 EVEREST ORGANICS LTD VONOPRAZAN FUMARATE
40644 A II 2024/10/16 CONCORD BIOTECH LTD VOCLOSPORIN
40668 A II 2024/10/16 SHENZHEN ALVANTIS PHARMA CO LTD TIRZEPATIDE
40679 A II 2024/10/16 SICHUAN KELUN PHARMACEUTICAL CO LTD OLAPARIB
40171 A II 2024/10/16 VANTAGE SPECIALTY CHEMICALS INC VYCERIN™ API GLYCERIN, USP
40323 A IV 2024/10/16 SYMRISE INC 127575 N&A CHERRY BERRY TYPE FL OS
31079 A II 2024/10/16 THE ALBERT B SABIN INSTITUTE INC CAD3-MARBURG VACCINE A195L FORMULATION
40649 A II 2024/10/15 INDENA SPA VOCLOSPORIN
40642 A V 2024/10/14 LONZA BIOLOGICS PORRINO SL TYPE V DRUG MASTER FILE LONZA BIOLOGICS PORRINO S.L. MANUFACTURING FACILITIES
40682 A II 2024/10/14 PORTON PHARMA SOLUTIONS LTD VONOPRAZAN FUMARATE
40301 A II 2024/10/14 BESTCHROM (ZHEJIANG) BIOSCIENCES LTD DEAE BESTAROSE HP
40448 A II 2024/10/13 CHENGDU YACHT BIOTECHNOLOGY CO LTD TACROLIMUS
40561 A II 2024/10/13 SHANGHAI KEZE YONGXIN BIOTECHNOLOGY CO LTD DMT-2'-OME-RG(IBU)-CE-PHOSPHORAMIDITE
40616 A III 2024/10/13 SHIJIAZHUANG XINFUDA MEDICAL PACKAGING CO LTD CHILD-RESISTANT CAP FOR ORAL PREPARATIONS
40415 A II 2024/10/11 HISAMITSU PHARMACEUTICAL CO INC HP-3150 TRANSDERMAL SYSTEM

数据库说明:

当前数据更新日期:2025年10月13日(该库为每季度更新),更多信息请点击此处查询美国FDA药品数据库
©2006-2025 DrugFuture->U.S. FDA Drug Master Files